Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of MenB and MenACWY Vaccines on Carriage in Young Adults
NCT01214850Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2010
- Primary completion
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant neisseria meningitidis group B nhba fusion protein, neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen in meningococcal disease, sponsored by Novartis. Started Sep 2010; status: completed.
02
Drugs
recombinant neisseria meningitidis group B nhba fusion proteinneisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01214850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214850.